Accelerated Approval: Acrotech’s Confirmatory Trial For Folotyn, Beleodaq More Than A Decade Behind Schedule

 
• By Sue Sutter
Delays sign
FDA says more delays may be encountered in the confirmatory trial program for Folotyn and Beleodaq. • Source: Shutterstock

More from US FDA Performance Tracker

More from Regulatory Trackers